Connect with us

Hi, what are you looking for?


What’s happening to Moderna shares on Wednesday?

moderna shares up on rsv vaccine data

Shares of Moderna Inc (NASDAQ: MRNA) gained as much as 8.0% on Wednesday after the biotech giant reported promising results for its respiratory syncytial virus vaccine in older adults.

CEO Bancel discussed the update on CNBC

In a clinical trial, the said vaccine was shown to be about 83% effective in preventing lower respiratory tract disease, as per the press release this morning.

Moderna now plans on requesting FDA (Food and Drug Administration) approval for its RSV vaccine by mid-2023. On CNBC’s “Squawk Box”, CEO Stephane Bancel said:

The other great news about mRNA vaccine is because all products use the same manufacturing process, we don’t have capacity constraint. We can use the same equipment, people, and raw material as with the COVID shot.

So far, there’s no FDA-approved treatment for the respiratory syncytial virus. Moderna shares are now 75% up versus just three months ago.

Moderna says its RSV vaccine is well-tolerated

More importantly, the pharmaceutical company did not identify any safety concerns in the clinical trial comprising 37,000 participants.

In placebo, 2.8% and in the active group, the vaccine group, 4.0%. So, it’s very close to the placebo group. We really like the high efficacy and very good tolerability.

According to Morgan Stanley, the adult RSV vaccine has a total addressable market of between $7.0 billion to $10 billion.

Last month, Moderna reported promising results for its candidate melanoma vaccine as well (read more). It’s expected to earn $4.66 a share in its current quarter versus a significantly higher $11.29 a year ago. Nonetheless, Wall Street continues to recommend buying Moderna shares.

The post What’s happening to Moderna shares on Wednesday? appeared first on Invezz.

You May Also Like


Mimiq, Inc is announcing today the launch of their new product, Mimiq Track, at CES as part of their latest product line to operate...


Bayerische Motoren Werke AG (ETR: BMW) shares have advanced more than 15% since the beginning of October 2022, and the current share price stands...

Editor's Pick

Real gross domestic product rose at a revised 3.2 percent annualized rate in the third quarter versus a 0.6 percent rate of decline in...

Editor's Pick

After the final lecture of my Fall 2022 International Economic Policy course (an undergraduate offering meant to introduce non-economics majors to the economics of...

Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2023